Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis
Status:
Terminated
Trial end date:
2020-01-16
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the efficacy of antibiotic therapy with any
antibiotic (IV) and IV (Nebcin®) tobramycin for 5 days followed by Solution for nebuliser
inhalation (Tobi®) for 9 days and antibiotic cures using 14 days of tobramycin IV. In the
case of positive results, the reduction of the duration of IV treatment of tobramycin from 14
days to 5 days would limit the risk of toxicity.